Li Zhenhui, Lin Song, Zhu Mei, Liu Xiaoman, Huang Xin
School of Chemistry and Chemical Engineering, Harbin Institute of Technology, Harbin 150001, China.
Molecules. 2025 Jan 9;30(2):232. doi: 10.3390/molecules30020232.
Macromolecule bactericides present challenges such as low biocompatibility and not being biodegradable, so broad-spectrum bactericides without accumulated bacteria resistance are now in urgent demand all over the world. Lysozyme, a kind of wide-spread natural enzyme easily extracted from nature, has become attractive for agriculture and medicine use. However, Gram-negative bacterial strains are highly resistant to natural lysozymes, which limits their practical application. In this study, rather than directly modifying antibacterial-active substance with lysozyme, we show an effective way to improve antibacterial performance by altering the hydrophobic functional groups of natural lysozymes and synthesize a type of hydrophobic modified lysozyme (HML). Compared with other modification methods, the antibacterial performance has been increased by over 50%. We investigated its antibacterial mechanism against Gram-negative bacteria and showed that HML could be used to treat pathogenic bacteria without obvious accumulated resistance appearance, which is a great advantage over commercial antibiotics. Overall, it is anticipated that HML could be potentially applied to food safety, infection therapy, and enzyme-medicine applications.
大分子杀菌剂存在生物相容性低和不可生物降解等挑战,因此目前全球迫切需要无细菌耐药性积累的广谱杀菌剂。溶菌酶是一种易于从自然界提取的广泛存在的天然酶,已在农业和医学应用中受到关注。然而,革兰氏阴性菌菌株对天然溶菌酶具有高度抗性,这限制了它们的实际应用。在本研究中,我们没有用溶菌酶直接修饰抗菌活性物质,而是展示了一种通过改变天然溶菌酶的疏水官能团来提高抗菌性能的有效方法,并合成了一种疏水修饰溶菌酶(HML)。与其他修饰方法相比,抗菌性能提高了50%以上。我们研究了其对革兰氏阴性菌的抗菌机制,并表明HML可用于治疗病原菌,且无明显的耐药性积累现象,这是优于商业抗生素的一大优势。总体而言,预计HML可能潜在地应用于食品安全、感染治疗和酶 - 药物应用。